HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant.

PubWeight™: 2.71‹?› | Rank: Top 1%

🔗 View Article (PMID 8096564)

Published in Lancet on April 03, 1993

Authors

S L Rowland-Jones1, D F Nixon, M C Aldhous, F Gotch, K Ariyoshi, N Hallam, J S Kroll, K Froebel, A McMichael

Author Affiliations

1: Molecular Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK.

Articles citing this

Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi. J Clin Invest (1998) 3.53

Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccine. J Infect Dis (2006) 3.40

Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers. Proc Natl Acad Sci U S A (1997) 3.02

Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen. J Virol (1999) 2.95

Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage. J Virol (1998) 2.82

Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1. J Exp Med (1994) 2.81

Putative immunodominant human immunodeficiency virus-specific CD8(+) T-cell responses cannot be predicted by major histocompatibility complex class I haplotype. J Virol (2000) 2.51

Human immunodeficiency virus type 1-specific immunity after genetic immunization is enhanced by modification of Gag and Pol expression. J Virol (2001) 2.12

Immunogenicity of multiple gene and clade human immunodeficiency virus type 1 DNA vaccines. J Virol (2003) 2.09

ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids. J Clin Invest (1995) 2.04

Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients. J Clin Invest (1994) 1.75

Strong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removal. PLoS One (2006) 1.73

Identification of novel HLA-A2-restricted human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte epitopes predicted by the HLA-A2 supertype peptide-binding motif. J Virol (2001) 1.65

Strong human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte activity in Sydney Blood Bank Cohort patients infected with nef-defective HIV type 1. J Virol (1999) 1.63

Identification and antigenicity of broadly cross-reactive and conserved human immunodeficiency virus type 1-derived helper T-lymphocyte epitopes. J Virol (2001) 1.62

Protection against simian/human immunodeficiency virus (SHIV) 89.6P in macaques after coimmunization with SHIV antigen and IL-15 plasmid. Proc Natl Acad Sci U S A (2007) 1.60

HV-1-specific cytotoxic T lymphocytes and breast milk HIV-1 transmission. J Infect Dis (2009) 1.57

Selection of virus variants and emergence of virus escape mutants after immunization with an epitope vaccine. J Virol (1998) 1.47

Evaluation of novel human immunodeficiency virus type 1 Gag DNA vaccines for protein expression in mammalian cells and induction of immune responses. J Virol (1999) 1.43

HIV-exposed uninfected children: a growing population with a vulnerable immune system? Clin Exp Immunol (2014) 1.42

Persistence of extraordinarily low levels of genetically homogeneous human immunodeficiency virus type 1 in exposed seronegative individuals. J Virol (2003) 1.28

Cellular immune responses in seronegative sexual contacts of acute hepatitis C patients. J Virol (2004) 1.25

Frequent detection of escape from cytotoxic T-lymphocyte recognition in perinatal human immunodeficiency virus (HIV) type 1 transmission: the ariel project for the prevention of transmission of HIV from mother to infant. J Virol (1999) 1.16

A phase I trial of preventive HIV vaccination with heterologous poxviral-vectors containing matching HIV-1 inserts in healthy HIV-uninfected subjects. Vaccine (2011) 1.11

Interleukin-12 (IL-12) enhancement of the cellular immune response against human immunodeficiency virus type 1 env antigen in a DNA prime/vaccinia virus boost vaccine regimen is time and dose dependent: suppressive effects of IL-12 boost are mediated by nitric oxide. J Virol (2000) 1.11

Protection of human immunodeficiency virus type 2-exposed seronegative macaques from mucosal simian immunodeficiency virus transmission. J Virol (1997) 1.11

Detailed characterization of T cell responses to herpes simplex virus-2 in immune seronegative persons. J Immunol (2010) 1.10

Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles. J Virol (2002) 1.10

Involvement of activating NK cell receptors and their modulation in pathogen immunity. J Biomed Biotechnol (2011) 1.10

Feline immunodeficiency virus vaccination: characterization of the immune correlates of protection. J Virol (1996) 1.08

Mother-to-child transmission of human immunodeficiency virus type 1. Epidemiol Rev (1996) 1.08

Microarray analysis of HIV resistant female sex workers reveal a gene expression signature pattern reminiscent of a lowered immune activation state. PLoS One (2012) 1.07

In vivo effects of HIV-1 exposure in the presence and absence of single-dose nevirapine on cellular plasma activation markers of infants born to HIV-1-seropositive mothers. J Acquir Immune Defic Syndr (2006) 1.06

Deficiency of HIV-Gag-specific T cells in early childhood correlates with poor viral containment. J Immunol (2008) 1.05

Feline immunodeficiency virus can be experimentally transmitted via milk during acute maternal infection. J Virol (1994) 1.04

Enhancement of primary and secondary cellular immune responses against human immunodeficiency virus type 1 gag by using DNA expression vectors that target Gag antigen to the secretory pathway. J Virol (2000) 1.02

Differences in HIV-specific T cell responses between HIV-exposed and -unexposed HIV-seronegative individuals. J Virol (2011) 1.02

A longitudinal study of feline immunodeficiency virus-specific cytotoxic T lymphocytes in experimentally infected cats, using antigen-specific induction. J Virol (1996) 0.99

The rhesus macaque pediatric SIV infection model - a valuable tool in understanding infant HIV-1 pathogenesis and for designing pediatric HIV-1 prevention strategies. Curr HIV Res (2009) 0.97

CD4(+)CD25(+) T regulatory cells inhibit CD8(+) IFN-gamma production during acute and chronic FIV infection utilizing a membrane TGF-beta-dependent mechanism. AIDS Res Hum Retroviruses (2010) 0.96

Reduced HIV-stimulated T-helper cell reactivity in cord blood with short-course antiretroviral treatment for prevention of maternal-infant transmission. Clin Exp Immunol (2001) 0.96

Potentially exposed but uninfected individuals produce cytotoxic and polyfunctional human immunodeficiency virus type 1-specific CD8(+) T-cell responses which can be defined to the epitope level. Clin Vaccine Immunol (2008) 0.96

Resistance to HIV infection. J Urban Health (2006) 0.96

Cytotoxic T lymphocyte activity and CD8 subpopulations in children at risk of HIV infection. Clin Exp Immunol (1994) 0.95

The role of infant immune responses and genetic factors in preventing HIV-1 acquisition and disease progression. Clin Exp Immunol (2003) 0.95

Cytotoxic and proliferative T cell responses in HIV-1-infected Macaca nemestrina. J Clin Invest (1995) 0.94

Impact of maternal HIV-1 viremia on lymphocyte subsets among HIV-exposed uninfected infants: protective mechanism or immunodeficiency. BMC Infect Dis (2014) 0.94

Detection of simian immunodeficiency virus (SIV)-specific CD8+ T cells in macaques protected from SIV challenge by prior SIV subunit vaccination. J Virol (1996) 0.94

Induction of feline immunodeficiency virus-specific cytotoxic T cells in vivo with carrier-free synthetic peptide. J Virol (1994) 0.93

Induction of feline immunodeficiency virus-specific cell-mediated and humoral immune responses following immunization with a multiple antigenic peptide from the envelope V3 domain. Immunology (1995) 0.92

Major histocompatibility complex class II DR alleles DRB1*1501 and those encoding HLA-DR13 are preferentially associated with a diminution in maternally transmitted human immunodeficiency virus 1 infection in different ethnic groups: determination by an automated sequence-based typing method. Proc Natl Acad Sci U S A (1995) 0.92

Preinfection human immunodeficiency virus (HIV)-specific cytotoxic T lymphocytes failed to prevent HIV type 1 infection from strains genetically unrelated to viruses in long-term exposed partners. J Virol (2009) 0.91

Pathogenesis of hepatitis C during pregnancy and childhood. Viruses (2012) 0.90

Baseline and Dynamic Expression of Activating NK Cell Receptors in the Control of Chronic Viral Infections: The Paradigm of HIV-1 and HCV. Front Immunol (2014) 0.89

Human leukocyte antigen class I supertypes and HIV-1 control in African Americans. J Virol (2009) 0.88

Dynamics of the CD8 T-cell response following yellow fever virus 17D immunization. Immunology (2009) 0.87

Protective immunity to HIV-1 in SCID/beige mice reconstituted with peripheral blood lymphocytes of exposed but uninfected individuals. Proc Natl Acad Sci U S A (1996) 0.87

A consecutive priming-boosting vaccination of mice with simian immunodeficiency virus (SIV) gag/pol DNA and recombinant vaccinia virus strain DIs elicits effective anti-SIV immunity. J Virol (2004) 0.87

TLR7/TLR8 Activation Restores Defective Cytokine Secretion by Myeloid Dendritic Cells but Not by Plasmacytoid Dendritic Cells in HIV-Infected Pregnant Women and Newborns. PLoS One (2013) 0.87

Pattern of Infectious Morbidity in HIV-Exposed Uninfected Infants and Children. Front Immunol (2016) 0.86

AIDS and the lung: update 1995. 4. Role of the human immunodeficiency virus within the lung. Thorax (1995) 0.85

Perforin-low memory CD8+ cells are the predominant T cells in normal humans that synthesize the beta -chemokine macrophage inflammatory protein-1beta. Proc Natl Acad Sci U S A (2001) 0.85

Selective induction of cell-mediated immunity and protection of rhesus macaques from chronic SHIV(KU2) infection by prophylactic vaccination with a conserved HIV-1 envelope peptide-cocktail. Virology (2007) 0.85

A single-nucleotide synonymous mutation in the gag gene controlling human immunodeficiency virus type 1 virion production. J Virol (2006) 0.85

Human immunodeficiency virus type 1 gag-specific mucosal immunity after oral immunization with papillomavirus pseudoviruses encoding gag. J Virol (2004) 0.85

Suppression of feline immunodeficiency virus replication in vitro by a soluble factor secreted by CD8+ T lymphocytes. Immunology (1999) 0.84

Differential regulatory T cell activity in HIV type 1-exposed seronegative individuals. AIDS Res Hum Retroviruses (2013) 0.84

Altered Memory T-Cell Responses to Bacillus Calmette-Guerin and Tetanus Toxoid Vaccination and Altered Cytokine Responses to Polyclonal Stimulation in HIV-Exposed Uninfected Kenyan Infants. PLoS One (2015) 0.82

Cellular immune correlates analysis of an HIV-1 preexposure prophylaxis trial. Proc Natl Acad Sci U S A (2015) 0.82

CD4+CD25+ T regulatory cells from FIV+ cats induce a unique anergic profile in CD8+ lymphocyte targets. Retrovirology (2010) 0.82

Dissecting the HIV-specific immune response: a systems biology approach. Curr Opin HIV AIDS (2012) 0.82

Development of an interferon-gamma ELISPOT assay to detect human T cell responses to HSV-2. Vaccine (2011) 0.80

Immune-based approaches to the prevention of mother-to-child transmission of HIV-1: active and passive immunization. Clin Perinatol (2010) 0.80

CD26/dipeptidyl peptidase IV (CD26/DPPIV) is highly expressed in peripheral blood of HIV-1 exposed uninfected female sex workers. Virol J (2010) 0.80

Evidence that high-dosage zidovudine at time of retrovirus exposure reduces antiviral efficacy. Antimicrob Agents Chemother (1996) 0.79

Evidence of HIV exposure and transient seroreactivity in archived HIV-negative severe hemophiliac sera. Virol J (2005) 0.79

The Immune System of HIV-Exposed Uninfected Infants. Front Immunol (2016) 0.79

Absence of reproducibly detectable low-level HIV viremia in highly exposed seronegative men and women. AIDS (2011) 0.77

Immune responses to human immunodeficiency virus type 1 in exposed but uninfected individuals: protection or chance? J Clin Invest (1994) 0.77

Decay kinetics of HIV-1 specific T cell responses in vertically HIV-1 exposed seronegative infants. Front Immunol (2012) 0.77

CD8+ clonality is associated with prolonged acute plasma viremia and altered mRNA cytokine profiles during the course of feline immunodeficiency virus infection. Vet Immunol Immunopathol (2012) 0.76

Maternal plasma and breastmilk viral loads are associated with HIV-1-specific cellular immune responses among HIV-1-exposed, uninfected infants in Kenya. Clin Exp Immunol (2015) 0.76

A Prospective Cohort Study of Common Childhood Infections in South African HIV-exposed Uninfected and HIV-unexposed Infants. Pediatr Infect Dis J (2017) 0.75

Immune approaches for the prevention of breast milk transmission of HIV-1. Adv Exp Med Biol (2012) 0.75

Persistently HIV-1 seronegative Nairobi sex workers are susceptible to in vitro infection. Can J Infect Dis (2000) 0.75

Articles by these authors

The time relations of the photo-electric changes in the eyeball of the frog. J Physiol (1903) 31.79

Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science (1998) 12.05

Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature (1991) 10.85

The delay of the electrical response of nerve to a second stimulus. J Physiol (1910) 9.35

HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med (2000) 5.79

HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat Med (1995) 5.22

An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants. Cell (2001) 4.79

Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2. Nature (1987) 4.66

PCR for capsular typing of Haemophilus influenzae. J Clin Microbiol (1994) 4.08

Global genetic structure and molecular epidemiology of encapsulated Haemophilus influenzae. Rev Infect Dis (1990) 4.06

Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy. J Virol (1999) 3.79

Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi. J Clin Invest (1998) 3.53

A specific inhibitor of the epidermal growth factor receptor tyrosine kinase. Science (1994) 3.05

Clonal population structure of encapsulated Haemophilus influenzae. Infect Immun (1988) 3.03

Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes. J Exp Med (1987) 3.02

Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells. J Clin Invest (1999) 3.00

Epidemiological profile and clinical associations of human bocavirus and other human parvoviruses. J Infect Dis (2006) 2.97

Cytotoxic T-cell recognition of HIV proteins and peptides. AIDS (1991) 2.83

High frequency of memory and effector gag specific cytotoxic T lymphocytes in HIV seropositive individuals. Int Immunol (1990) 2.71

Evolutionary genetics of the encapsulated strains of Haemophilus influenzae. Proc Natl Acad Sci U S A (1988) 2.68

Lifetime exposure to environmental lead and children's intelligence at 11-13 years: the Port Pirie cohort study. BMJ (1996) 2.67

The association between the HLA system and disease. Prog Med Genet (1977) 2.67

Presentation of viral antigen controlled by a gene in the major histocompatibility complex. Nature (1990) 2.65

Loss of blood CD11c(+) myeloid and CD11c(-) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load. Blood (2001) 2.57

Terminal transferase-positive human bone marrow cells exhibit the antigenic phenotype of common acute lymphoblastic leukemia. J Immunol (1979) 2.53

HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy. J Clin Invest (1999) 2.42

The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9. Eur J Immunol (1997) 2.36

Safety and activity of saquinavir in HIV infection. Lancet (1995) 2.32

Recognition of HLA-B27 and related antigen by a monoclonal antibody. Hum Immunol (1982) 2.30

Nef triggers a transcriptional program in T cells imitating single-signal T cell activation and inducing HIV virulence mediators. Immunity (2001) 2.30

The effect of commencing combination antiretroviral therapy soon after human immunodeficiency virus type 1 infection on viral replication and antiviral immune responses. J Infect Dis (1999) 2.27

Bacterial copper- and zinc-cofactored superoxide dismutase contributes to the pathogenesis of systemic salmonellosis. Mol Microbiol (1997) 2.23

Temperature and Excitability. J Physiol (1896) 2.21

The role of bacterial polysaccharide capsules as virulence factors. Curr Top Microbiol Immunol (1990) 2.18

CD8(+) lymphocytes respond to different HIV epitopes in seronegative and infected subjects. J Clin Invest (2001) 2.15

Mycoplasma fermentans in individuals seropositive and seronegative for HIV-1. Lancet (1993) 2.05

Cytotoxic lymphocytes from rats depleted of thymus processed cells. Nat New Biol (1971) 2.02

Recognition of influenza A matrix protein by HLA-A2-restricted cytotoxic T lymphocytes. Use of analogues to orientate the matrix peptide in the HLA-A2 binding site. J Exp Med (1988) 1.97

The human thymic microenvironment: an immunohistologic study. J Immunol (1980) 1.94

Plasmacytoid dendritic cells are highly susceptible to human immunodeficiency virus type 1 infection and release infectious virus. J Virol (2001) 1.92

Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects. Proc Natl Acad Sci U S A (2001) 1.89

The time-relations of the photo-electric changes produced in the eyeball of the frog by means of coloured light. J Physiol (1904) 1.88

Distribution of HLA class 1 antigens in normal human tissue and in mammary cancer. J Clin Pathol (1981) 1.87

Deletion of the CD4 silencer element supports a stochastic mechanism of thymocyte lineage commitment. Nat Immunol (2001) 1.74

Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime. Vaccine (1998) 1.74

Mechanisms of protection induced by attenuated simian immunodeficiency virus. II. Lymphocyte depletion does not abrogate protection. AIDS Res Hum Retroviruses (1998) 1.73

Immune responses in HIV-exposed seronegatives: have they repelled the virus? Curr Opin Immunol (1995) 1.73

Periplasmic superoxide dismutase in meningococcal pathogenicity. Infect Immun (1998) 1.69

Functional heterogeneity of cytokines and cytolytic effector molecules in human CD8+ T lymphocytes. J Immunol (2001) 1.68

A human X-linked antigen defined by a monoclonal antibody. Somatic Cell Genet (1980) 1.64

Impaired cell mediated immunity in haemophilia in the absence of infection with human immunodeficiency virus. Br Med J (Clin Res Ed) (1986) 1.64

Strong human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte activity in Sydney Blood Bank Cohort patients infected with nef-defective HIV type 1. J Virol (1999) 1.63

Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria. Lancet (1995) 1.62

HPV16 DNA and prediction of high-grade CIN. Lancet (1992) 1.61

Long term effects of radiation of T and B lymphocytes in peripheral blood of patients with Hodgkin's disease. J Clin Invest (1976) 1.59

HLA restriction of human cytotoxic T lymphocytes specific for influenza virus. Poor recognition of virus associated with HLA A2. J Exp Med (1978) 1.56

Low peripheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infection. J Hum Virol (1999) 1.54

Human papillomavirus testing and the management of women with mildly abnormal cervical smears: an observational study. BMJ (2001) 1.53

Region II of the Haemophilus influenzae type be capsulation locus is involved in serotype-specific polysaccharide synthesis. Mol Microbiol (1995) 1.52

Role of cellular immunity in protection against HIV infection. Adv Immunol (1997) 1.51

Subpopulations of normal and leukemic human thymocytes: an analysis with the use of monoclonal antibodies. J Natl Cancer Inst (1980) 1.50

Co-evolution of human immunodeficiency virus and cytotoxic T-lymphocyte responses. Immunol Rev (1997) 1.49

Cytotoxic T lymphocyte lysis inhibited by viable HIV mutants. Science (1995) 1.48

A sequence pattern for peptides presented to cytotoxic T lymphocytes by HLA B8 revealed by analysis of epitopes and eluted peptides. Eur J Immunol (1993) 1.48

The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection. AIDS (2001) 1.46

Note on the so-called Tendon Reflex. J Physiol (1896) 1.46

Rapid quantification of SIV-specific CD8 T cell responses with recombinant vaccinia virus ELISPOT or cytokine flow cytometry. AIDS (2000) 1.45

Impact of baseline polymorphisms in RT and protease on outcome of highly active antiretroviral therapy in HIV-1-infected African patients. AIDS (2001) 1.44

Summary of North American Hair Research Society (NAHRS)-sponsored Workshop on Cicatricial Alopecia, Duke University Medical Center, February 10 and 11, 2001. J Am Acad Dermatol (2003) 1.42

Contribution of maternal viral load to HIV-1 transmission. Lancet (1992) 1.41

Altered subjective appetite parameters in Crohn's disease patients. Clin Nutr (2001) 1.41

A novel technique for the fluorometric assessment of T lymphocyte antigen specific lysis. J Immunol Methods (2001) 1.41

DNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum: immunogenicity in mice. Vaccine (1998) 1.40

Enhancement by recombinant human interferon alfa of the reversal of multidrug resistance by MRK-16 monoclonal antibody. J Natl Cancer Inst (1995) 1.39

Tyrosine kinase inhibitors. 8. An unusually steep structure-activity relationship for analogues of 4-(3-bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a potent inhibitor of the epidermal growth factor receptor. J Med Chem (1996) 1.39

The molecular basis of pathogenicity in Haemophilus influenzae: comparative virulence of genetically-related capsular transformants and correlation with changes at the capsulation locus cap. Microb Pathog (1989) 1.38

Reduced allorecognition of adenovirus-2 infected cells. J Immunol (1987) 1.38

Cellular and humoral antigenic epitopes in HIV and SIV. Immunology (1992) 1.38

Association of environmental tobacco smoking exposure with an increased risk of hospital admissions for pneumonia in children under 5 years of age in Vietnam. Thorax (2009) 1.37

The human cytotoxic T cell response to influenza A vaccination. Clin Exp Immunol (1981) 1.37

Cross-clade recognition of p55 by cytotoxic T lymphocytes in HIV-1 infection. AIDS (1998) 1.35

A broad range of chemokine receptors are used by primary isolates of human immunodeficiency virus type 2 as coreceptors with CD4. J Virol (1998) 1.35

Enhancement of human immunodeficiency virus type 1-specific CD4 and CD8 T cell responses in chronically infected persons after temporary treatment interruption. J Infect Dis (2000) 1.33

Broadly cross-reactive HIV-specific cytotoxic T-lymphocytes in highly-exposed persistently seronegative donors. Immunol Lett (1999) 1.32

Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice. J Gen Virol (1998) 1.32

Structural homologies between two HLA B27-restricted peptides suggest residues important for interaction with HLA B27. Int Immunol (1990) 1.31

Requirement of mature dendritic cells for efficient activation of influenza A-specific memory CD8+ T cells. J Immunol (2000) 1.31

Identification of the nonamer peptide from influenza A matrix protein and the role of pockets of HLA-A2 in its recognition by cytotoxic T lymphocytes. Eur J Immunol (1992) 1.29

Ovarian endometriosis associated with ovarian carcinoma: a clinicopathological and immunohistochemical study. Gynecol Oncol (2000) 1.28

Maternal plasma viral RNA levels determine marked differences in mother-to-child transmission rates of HIV-1 and HIV-2 in The Gambia. MRC/Gambia Government/University College London Medical School working group on mother-child transmission of HIV. AIDS (2000) 1.28

The electrical response of nerve to two stimuli. J Physiol (1899) 1.27

Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations. Clin Exp Immunol (2004) 1.26

Chronic enteroviral meningoencephalitis in agammaglobulinemia: case report and literature review. J Clin Immunol (1992) 1.26